{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:08:05Z","timestamp":1762506485480},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"DOI":"10.1309\/ajcpmjkbc6vja1sp","type":"journal-article","created":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T18:35:55Z","timestamp":1421433355000},"page":"234-240","source":"Crossref","is-referenced-by-count":36,"title":["A Hybrid Approach to Urine Drug Testing Using High-Resolution Mass Spectrometry and Select Immunoassays"],"prefix":"10.1093","volume":"143","author":[{"given":"Gwendolyn A.","family":"McMillin","sequence":"first","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT."},{"name":"Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Marin","sequence":"additional","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamisha L.","family":"Johnson-Davis","sequence":"additional","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT."},{"name":"Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan G.","family":"Lawlor","sequence":"additional","affiliation":[{"name":"ARUP Laboratories, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick G.","family":"Strathmann","sequence":"additional","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT."},{"name":"Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,2,1]]},"reference":[{"key":"key\n\t\t\t\t20180602033919_b1-1430234","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3810\/pgm.2011.11.2502","article-title":"A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management","volume":"123","author":"McCarberg","year":"2011","journal-title":"Postgrad Med"},{"key":"key\n\t\t\t\t20180602033919_b2-1430234","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/papr.12011","article-title":"Prescription patterns of pain medicine physicians","volume":"13","author":"Benzon","year":"2013","journal-title":"Pain Pract"},{"issue":"suppl","key":"key\n\t\t\t\t20180602033919_b3-1430234","first-page":"S67","article-title":"American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2\u2014guidance","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"issue":"suppl","key":"key\n\t\t\t\t20180602033919_b4-1430234","first-page":"ES119","article-title":"Urine drug testing: current recommendations and best practices","volume":"15","author":"Owen","year":"2012","journal-title":"Pain Physician"},{"key":"key\n\t\t\t\t20180602033919_b5-1430234","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/FTD.0b013e3181c11fba","article-title":"LC-MS\/MS extends the range of drug analysis in pain patients","volume":"31","author":"Mikel","year":"2009","journal-title":"Ther Drug Monitor"},{"key":"key\n\t\t\t\t20180602033919_b6-1430234","doi-asserted-by":"crossref","first-page":"71","DOI":"10.36076\/ppj.2010\/13\/71","article-title":"Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS\/MS in pain management population","volume":"13","author":"West","year":"2010","journal-title":"Pain Physician"},{"key":"key\n\t\t\t\t20180602033919_b7-1430234","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/pme.12207","article-title":"Optimizing urine drug testing for monitoring medication compliance in pain management","volume":"14","author":"Melanson","year":"2013","journal-title":"Pain Med"},{"key":"key\n\t\t\t\t20180602033919_b8-1430234","first-page":"273","article-title":"An evaluation of the diagnostic accuracy of liquid chromatography\u2013tandem mass spectrometry versus immunoassay drug testing in pain patients","volume":"13","author":"Pesce","year":"2010","journal-title":"Pain Physician"},{"key":"key\n\t\t\t\t20180602033919_b9-1430234","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/jat\/bks061","article-title":"Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS","volume":"36","author":"Marin","year":"2012","journal-title":"J Anal Toxicol"},{"key":"key\n\t\t\t\t20180602033919_b10-1430234","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jat\/31.7.359","article-title":"Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS","volume":"31","author":"Feng","year":"2007","journal-title":"J Anal Toxicol"},{"key":"key\n\t\t\t\t20180602033919_b11-1430234","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jat\/bks071","article-title":"Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting","volume":"36","author":"Crews","year":"2012","journal-title":"J Anal Toxicol"},{"key":"key\n\t\t\t\t20180602033919_b12-1430234","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2471\/BLT.12.113183","article-title":"Phenobarbital: missing in action","volume":"90","author":"Ilangaratne","year":"2012","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180602033919_b13-1430234","first-page":"329","article-title":"The history of barbiturates a century after their clinical introduction","volume":"1","author":"Lopez-Munoz","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"key":"key\n\t\t\t\t20180602033919_b14-1430234","first-page":"18","article-title":"Risk of drug dependence and abuse posed by barbiturate-containing analgesics","volume":"6","author":"Sellers","year":"1999","journal-title":"Can J Clin Pharmacol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/143\/2\/234\/24999359\/ajcpath143-0234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T22:58:19Z","timestamp":1651013899000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/143\/2\/234\/1766944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,1]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpmjkbc6vja1sp","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,2,1]]},"published":{"date-parts":[[2015,2,1]]}}}